de Monbrison Frédérique, Maitrejean Mathias, Latour Christine, Bugnazet Franck, Peyron François, Barron Denis, Picot Stephane
E.A. 3732, Université Claude Bernard Lyon I, Laboratoire de Parasitologie, Mycologie Médicale et Maladies Tropicales, 8 avenue Rockefeller, 69373 Lyon Cedex 08, France.
Acta Trop. 2006 Jan;97(1):102-7. doi: 10.1016/j.actatropica.2005.09.004. Epub 2005 Oct 26.
Multidrug-resistant Plasmodium falciparum strains are an increasing problem in endemic areas and are partly responsible for the worsening malaria situation around the world. New cheap and effective compounds active in combination with available drug in the field are urgently needed. The aim of this work was to explore the potential antiplasmodial effect of flavonoid derivatives on parasites growth in vitro. In vitro antiplasmodial activity of dehydrosilybin and 8-(1;1)-DMA-kaempferide has been evaluated by real time PCR for five P. falciparum strains. Both revealed significative antimalarial activity against the different strains. Since this drug family has been largely used and well-tolerated in humans, flavonoid derivatives could be in the near future associated with already available drugs in order to delay the spread of P. falciparum resistance.
耐多药恶性疟原虫菌株在疟疾流行地区正成为一个日益严重的问题,并且在一定程度上导致了全球疟疾形势的恶化。迫切需要新的廉价且有效的化合物,这些化合物能够与该领域现有的药物联合发挥作用。这项工作的目的是探索黄酮类衍生物对体外寄生虫生长的潜在抗疟作用。通过实时聚合酶链反应(PCR)评估了脱氢水飞蓟宾和8-(1;1)-二甲基烯丙基山奈酚对五种恶性疟原虫菌株的体外抗疟活性。两者均显示出对不同菌株具有显著的抗疟活性。由于这类药物在人类中已被广泛使用且耐受性良好,黄酮类衍生物在不久的将来可能会与现有药物联合使用,以延缓恶性疟原虫耐药性的传播。